Mark R Janse van Mantgem
8PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 26, 2025
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis.Ruben P A van Eijk, Frederik J Steyn, Mark R Janse van Mantgem
|Jun 14, 2024
Association Between Hypothalamic Volume and Metabolism, Cognition, and Behavior in Patients With Amyotrophic Lateral Sclerosis.Annebelle Michielsen, Kevin van Veenhuijzen, Mark R Janse van Mantgem
|Feb 13, 2024
Variation in Resting Metabolic Rate Affects Identification of Metabolic Change in Geographically Distinct Cohorts of Patients With ALS.Cory J Holdom, Mark R Janse van Mantgem, Ji He
|Jan 24, 2024
A comparison between bioelectrical impedance analysis and air-displacement plethysmography in assessing fat-free mass in patients with motor neurone diseases: a cross-sectional study.Mark R Janse van Mantgem, Maaike L Soors D'Ancona, Myrte Meyjes
|Dec 02, 2022
Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis: A Meta-analysis and Population-Based Study.Mark R Janse van Mantgem, Wouter van Rheenen, Anemone V Hackeng
|Jul 03, 2021
Venous creatinine as a biomarker for loss of fat-free mass and disease progression in patients with amyotrophic lateral sclerosis.Cory J Holdom, Mark R Janse van Mantgem, Ruben P A van Eijk
Pageof 2
Frequent Collaborators
7 joint publications
Ruben van Eijk
4 joint publications
Jan H Veldink
3 joint publications
Shyuan T Ngo
2 joint publications
Leonard H van den Berg
2 joint publications
Robert D Henderson
2 joint publications
Frederik J Steyn
1 joint publications
Merel O Mol
1 joint publications
Yolande A L Pijnenburg
1 joint publications
Meike Vernooij
1 joint publications
John C van Swieten
